The estimated Net Worth of Ingrid Delaet is at least $2.35 Milione dollars as of 13 August 2024. Ingrid Delaet owns over 7,143 units of Neurocrine Biosciences stock worth over $304,525 and over the last 2 years Ingrid sold NBIX stock worth over $2,047,708.
Ingrid has made over 15 trades of the Neurocrine Biosciences stock since 2023, according to the Form 4 filled with the SEC. Most recently Ingrid sold 7,143 units of NBIX stock worth $1,072,164 on 13 August 2024.
The largest trade Ingrid's ever made was selling 7,143 units of Neurocrine Biosciences stock on 13 August 2024 worth over $1,072,164. On average, Ingrid trades about 2,049 units every 22 days since 2023. As of 13 August 2024 Ingrid still owns at least 2,507 units of Neurocrine Biosciences stock.
You can see the complete history of Ingrid Delaet stock trades at the bottom of the page.
Ingrid's mailing address filed with the SEC is 12780, El Camino Real, San Diego, San Diego County, California, 92014, United States.
Over the last 22 years, insiders at Neurocrine Biosciences have traded over $159,913,426 worth of Neurocrine Biosciences stock and bought 103,400 units worth $589,660 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog... e Richard F Pops. On average, Neurocrine Biosciences executives and independent directors trade stock every 8 days with the average trade being worth of $1,567,813. The most recent stock trade was executed by William H Rastetter on 15 August 2024, trading 14,250 units of NBIX stock currently worth $2,090,333.
neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders
Neurocrine Biosciences executives and other stock owners filed with the SEC include: